API de banco de dados de medicamentos do Brasil

{
  "sourceUrl": "https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/cmed/precos",
  "retrievedAt": "2026-10-20T07:01:32.181Z",
  "licence": {
    "id": "LicenseRef-CMED-Lista-Precos",
    "url": "https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/cmed/precos",
    "scope": "current consumer price list (PF and PMC) linked from the CMED prices page",
    "termsUrl": "https://creativecommons.org/licenses/by-nd/3.0/deed.pt_BR",
    "reviewedAt": "2026-09-29",
    "attribution": "Fonte: Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva/ANVISA — Lista de Preços de Medicamentos (Preços Fábrica e Máximos ao Consumidor)",
    "documentsIncluded": false
  },
  "limitations": [
    "Every presentation of the current CMED consumer price list (Preço Fábrica and Preço Máximo ao Consumidor): medicines with a CMED price, not ANVISA’s complete registration register.",
    "The list carries no registration status; being priced does not establish a valid registration, current marketing or availability. \"COMERCIALIZAÇÃO <year>\" is the holder’s report for that past year only.",
    "The stripe (tarja) is the prescription classification: red and black stripes are sold under prescription and \"Sem Tarja\" without one; \"- (*)\" means ANVISA’s Datavisa records carry no stripe, so the classification stays unknown. No patient eligibility is inferred.",
    "Prices are regulatory ceilings in BRL per ICMS rate, not transaction prices; the PMC is omitted for hospital-restricted packs.",
    "The reviewed October 9, 2026 preamble states no separate price-validity date; pricesValidFrom stays null, independently of the publication date.",
    "Therapeutic classes are the list’s own class codes, not WHO ATC codes.",
    "gov.br publishes its site content under CC BY-ND 3.0. ANVISA also lists these price data as open data (Plano de Dados Abertos 2023–2025), which Decreto 8.777/2016 defines as freely usable with attribution, and official acts are outside copyright (Lei 9.610/1998, art. 8). Medifontis restructures the list into records; whether the no-derivatives notice applies is not resolved."
  ]
}